JPS6126984B2 - - Google Patents
Info
- Publication number
- JPS6126984B2 JPS6126984B2 JP55104708A JP10470880A JPS6126984B2 JP S6126984 B2 JPS6126984 B2 JP S6126984B2 JP 55104708 A JP55104708 A JP 55104708A JP 10470880 A JP10470880 A JP 10470880A JP S6126984 B2 JPS6126984 B2 JP S6126984B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound according
- formula
- dioxo
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 27
- -1 β-hydroxyethyl group Chemical group 0.000 claims description 21
- BFTCDHXECYYHTM-CCEZHUSRSA-N (e)-9,12-dioxooctadec-10-enamide Chemical class CCCCCCC(=O)\C=C\C(=O)CCCCCCCC(N)=O BFTCDHXECYYHTM-CCEZHUSRSA-N 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WYLMMQRVMQAKNJ-CCEZHUSRSA-N (e)-9,12-dioxooctadec-10-enoic acid Chemical compound CCCCCCC(=O)\C=C\C(=O)CCCCCCCC(O)=O WYLMMQRVMQAKNJ-CCEZHUSRSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- KYNCBEZYCRQPEO-WUKNDPDISA-N (E)-9,12-dioxo-N-propan-2-yloctadec-10-enamide Chemical compound CCCCCCC(=O)\C=C\C(=O)CCCCCCCC(=O)NC(C)C KYNCBEZYCRQPEO-WUKNDPDISA-N 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N N-butylamine Natural products CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- BRZBEIPHKZABTC-UHFFFAOYSA-N 1-(butylamino)-3-(3-methoxyphenoxy)propan-2-ol Chemical compound CCCCNCC(O)COC1=CC=CC(OC)=C1 BRZBEIPHKZABTC-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 231100000216 vascular lesion Toxicity 0.000 description 2
- HISOQHKTBABZHD-UHFFFAOYSA-N 1-ethoxy-3-(propan-2-ylamino)propan-2-ol Chemical compound CCOCC(O)CNC(C)C HISOQHKTBABZHD-UHFFFAOYSA-N 0.000 description 1
- UCGYCLBMTBEQQM-UHFFFAOYSA-N 2-[(3-methoxyphenoxy)methyl]oxirane Chemical compound COC1=CC=CC(OCC2OC2)=C1 UCGYCLBMTBEQQM-UHFFFAOYSA-N 0.000 description 1
- GZCPWFOPXIDRDP-UHFFFAOYSA-N 3-(propan-2-ylamino)propan-1-ol Chemical compound CC(C)NCCCO GZCPWFOPXIDRDP-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-M carbonochloridate Chemical compound [O-]C(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VXGABWCSZZWXPC-UHFFFAOYSA-N methyl 2-(methylamino)acetate Chemical compound CNCC(=O)OC VXGABWCSZZWXPC-UHFFFAOYSA-N 0.000 description 1
- HDCAZTXEZQWTIJ-UHFFFAOYSA-N n,n',n'-triethylethane-1,2-diamine Chemical compound CCNCCN(CC)CC HDCAZTXEZQWTIJ-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- ADXGNEYLLLSOAR-UHFFFAOYSA-N tasosartan Chemical compound C12=NC(C)=NC(C)=C2CCC(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1C=1N=NNN=1 ADXGNEYLLLSOAR-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- LKOVPWSSZFDYPG-WUKNDPDISA-N trans-octadec-2-enoic acid Chemical compound CCCCCCCCCCCCCCC\C=C\C(O)=O LKOVPWSSZFDYPG-WUKNDPDISA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10470880A JPS5728038A (en) | 1980-07-29 | 1980-07-29 | Octadecenoic acid amide |
| KR1019810000685A KR840001670B1 (ko) | 1980-07-29 | 1981-03-02 | 옥탄데센산 아미드의 제조방법 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10470880A JPS5728038A (en) | 1980-07-29 | 1980-07-29 | Octadecenoic acid amide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5728038A JPS5728038A (en) | 1982-02-15 |
| JPS6126984B2 true JPS6126984B2 (cs) | 1986-06-23 |
Family
ID=14387977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10470880A Granted JPS5728038A (en) | 1980-07-29 | 1980-07-29 | Octadecenoic acid amide |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5728038A (cs) |
| KR (1) | KR840001670B1 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010017550A2 (en) * | 2008-08-08 | 2010-02-11 | University Of Florida Research Foundation, Inc. | Lipid compounds for supression of tumorigenesis |
-
1980
- 1980-07-29 JP JP10470880A patent/JPS5728038A/ja active Granted
-
1981
- 1981-03-02 KR KR1019810000685A patent/KR840001670B1/ko active
Also Published As
| Publication number | Publication date |
|---|---|
| KR840001670B1 (ko) | 1984-10-13 |
| KR830005116A (ko) | 1983-07-23 |
| JPS5728038A (en) | 1982-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ294549B6 (cs) | Montážní spojka pro úseky vedení kabelů a výsledné úseky vedení kabelů | |
| EP0068968B1 (fr) | Nouveaux médicaments contenant à titre de substance active des composés du type arylbenzènesulfonamide et leurs procédés de préparation | |
| FR2500832A1 (fr) | Composes de derives de bis (carboxamide) et composition pharmaceutique comprenant ces composes | |
| US5134151A (en) | 2-picolylamine derivatives | |
| PL175707B1 (pl) | Nowe estry 1-aryloksy-3-alkiloamino-2-propanolu | |
| JPS6126984B2 (cs) | ||
| US4145443A (en) | Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents | |
| US4599205A (en) | 1-O-alkyl-3-amino-propan-1.2-diol-2-O-phospholipids | |
| KR840001669B1 (ko) | 옥타데센산 아미드의 제법 | |
| JPH0144708B2 (cs) | ||
| JPS6323986B2 (cs) | ||
| EP0151052B1 (fr) | Aminoéthylimidazole, composition pharmaceutique en contenant et procédé de préparation | |
| JPH033668B2 (cs) | ||
| JPH061776A (ja) | 置換ピラジンカルボニトリルの製造方法 | |
| JP2671401B2 (ja) | α‐アミノチオアセトアミド誘導体およびその製造法 | |
| JP2007513113A (ja) | 抗高血圧薬剤のニトロオキシ誘導体 | |
| GB2025393A (en) | Ethyleneglycol diesters and process for producing them | |
| JP4156739B2 (ja) | モノアシルピペラジン誘導体の製造方法 | |
| HU185953B (en) | Process for producing new 4.cabamoyloxy-oxaza-phosphorines | |
| JPH033666B2 (cs) | ||
| JPH0692391B2 (ja) | １，４−ジヒドロピリジン誘導体 | |
| JPS5946250A (ja) | エピニンエステル類 | |
| JPH0459315B2 (cs) | ||
| JPH0142263B2 (cs) | ||
| JPS62114960A (ja) | ４−ヒドロキシインド−ル誘導体、その製法及びその用途 |